关注
Yuqian Yan
Yuqian Yan
在 Mayo.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
RAD21 mutations cause a human cohesinopathy
MA Deardorff, JJ Wilde, M Albrecht, E Dickinson, S Tennstedt, ...
The American Journal of Human Genetics 90 (6), 1014-1027, 2012
3242012
Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT–mTORC1 activation
P Zhang, D Wang, Y Zhao, S Ren, K Gao, Z Ye, S Wang, CW Pan, Y Zhu, ...
Nature medicine 23 (9), 1055-1062, 2017
2642017
Phosphorylated RB promotes cancer immunity by inhibiting NF-κB activation and PD-L1 expression
X Jin, D Ding, Y Yan, H Li, B Wang, L Ma, Z Ye, T Ma, Q Wu, ...
Molecular cell 73 (1), 22-35. e6, 2019
2162019
DUB3 promotes BET inhibitor resistance and cancer progression by deubiquitinating BRD4
X Jin, Y Yan, D Wang, D Ding, T Ma, Z Ye, R Jimenez, L Wang, H Wu, ...
Molecular cell 71 (4), 592-605. e4, 2018
1422018
Rad21-cohesin haploinsufficiency impedes DNA repair and enhances gastrointestinal radiosensitivity in mice
H Xu, K Balakrishnan, J Malaterre, M Beasley, Y Yan, J Essers, ...
PloS one 5 (8), e12112, 2010
1272010
Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancers
H Xu, M Yan, J Patra, R Natrajan, Y Yan, S Swagemakers, ...
Breast Cancer Research 13, 1-10, 2011
1102011
Inhibiting histone deacetylases suppresses glucose metabolism and hepatocellular carcinoma growth by restoring FBP1 expression
J Yang, X Jin, Y Yan, Y Shao, Y Pan, LR Roberts, J Zhang, H Huang, ...
Scientific Reports 7 (1), 43864, 2017
1042017
RAD21 cohesin overexpression is a prognostic and predictive marker exacerbating poor prognosis in KRAS mutant colorectal carcinomas
S Deb, H Xu, J Tuynman, J George, Y Yan, J Li, RL Ward, N Mortensen, ...
British journal of cancer 110 (6), 1606-1613, 2014
982014
Interplay among PI3K/AKT, PTEN/FOXO and AR signaling in prostate cancer
Y Yan, H Huang
Prostate cancer: Cellular and genetic mechanisms of disease development and …, 2019
852019
Cohesin Rad21 mediates loss of heterozygosity and is upregulated via Wnt promoting transcriptional dysregulation in gastrointestinal tumors
H Xu, Y Yan, S Deb, D Rangasamy, M Germann, J Malaterre, NC Eder, ...
Cell reports 9 (5), 1781-1797, 2014
792014
Destruction of DNA-Binding Proteins by Programmable Oligonucleotide PROTAC (O'PROTAC): Effective Targeting of LEF1 and ERG
J Shao, Y Yan, D Ding, DW Wang, Y He, Y Pan, W Yan, A Kharbanda, ...
Adv Sci, 2021
752021
The novel BET‐CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild‐type prostate cancer
Y Yan, J Ma, D Wang, D Lin, X Pang, S Wang, Y Zhao, L Shi, H Xue, ...
EMBO molecular medicine 11 (11), e10659, 2019
732019
Loss of FOXO1 cooperates with TMPRSS2–ERG overexpression to promote prostate tumorigenesis and cell invasion
Y Yang, AM Blee, D Wang, J An, Y Pan, Y Yan, T Ma, Y He, J Dugdale, ...
Cancer research 77 (23), 6524-6537, 2017
652017
FOXA1 overexpression suppresses interferon signaling and immune response in cancer
Y He, L Wang, T Wei, YT Xiao, H Sheng, H Su, DP Hollern, X Zhang, J Ma, ...
The Journal of clinical investigation 131 (14), 2021
622021
TMPRSS2-ERG Controls Luminal Epithelial Lineage and Antiandrogen Sensitivity in PTEN and TP53-Mutated Prostate Cancer
AM Blee, Y He, Y Yang, Z Ye, Y Yan, Y Pan, T Ma, J Dugdale, E Kuehn, ...
Clinical Cancer Research 24 (18), 4551-4565, 2018
612018
Dual inhibition of AKT‐mTOR and AR signaling by targeting HDAC3 in PTEN‐ or SPOP‐mutated prostate cancer
Y Yan, J An, Y Yang, D Wu, Y Bai, W Cao, L Ma, J Chen, Z Yu, Y He, X Jin, ...
EMBO molecular medicine 10 (4), e8478, 2018
532018
HDAC5 loss impairs RB repression of pro-oncogenic genes and confers CDK4/6 inhibitor resistance in cancer
Y Zhou, X Jin, J Ma, D Ding, Z Huang, H Sheng, Y Yan, Y Pan, T Wei, ...
Cancer research 81 (6), 1486-1499, 2021
502021
Induction of apoptosis and autophagic cell death by the vanillin derivative 6-bromine-5-hydroxy-4-methoxybenzaldehyde is accompanied by the cleavage of DNA-PKcs and rapid …
YQ Yan, B Zhang, L Wang, YH Xie, T Peng, B Bai, PK Zhou
Cancer letters 252 (2), 280-289, 2007
412007
DNA damage promotes TMPRSS2-ERG oncoprotein destruction and prostate cancer suppression via signaling converged by GSK3β and WEE1
Z Hong, W Zhang, D Ding, Z Huang, Y Yan, W Cao, Y Pan, X Hou, ...
Molecular Cell 79 (6), 1008-1023. e4, 2020
372020
ATM-phosphorylated SPOP contributes to 53BP1 exclusion from chromatin during DNA replication
D Wang, J Ma, MV Botuyan, G Cui, Y Yan, D Ding, Y Zhou, EW Krueger, ...
Science Advances 7 (25), eabd9208, 2021
332021
系统目前无法执行此操作,请稍后再试。
文章 1–20